← All trials
NCT04818489
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 25, 2021
- Primary completion
- Aug 25, 2021
- Completion date
- Oct 20, 2021
- First posted
- Mar 26, 2021
- Last posted
- Nov 9, 2021
- Enrollment
- 260
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ClinAmygateLead sponsor
- ClinAmygateReponsible party - principal investigator
- Ain Shams UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.